Ambulatory - not office - blood pressures decline during hormone replacement therapy in healthy postmenopausal women

American Journal of Hypertension

Volumn 11, Issue 10 I, 1998, Pages 1147-1152

  Van Ittersum, Frans J ^a   Van Baal, W Marchien ^b   Kenemans, Peter ^b   Mijatovic, Velja ^b   Donker, Ab J M ^a   Van Der Mooren, Marius J ^b   Stehouwer, Coen D A ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hormone replacement therapy; Office blood pressures; Postmenopausal women; Twenty four hour ambulatory blood pressure monitoring

Indexed keywords

DYDROGESTERONE; ESTRADIOL; UNCLASSIFIED DRUG;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OUTPATIENT DEPARTMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ANALYSIS OF VARIANCE; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; DRUG COMBINATIONS; DYDROGESTERONE; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; OFFICE VISITS; POSTMENOPAUSE; PROGESTERONE CONGENERS; PROSPECTIVE STUDIES; REFERENCE VALUES;

EID: 0031758170     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00165-4     Document Type: Article

References (22)

1. Kannel WB, Wilson PW: Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995;155:57-61.
2. Stampfer MJ, Colditz GA: Estrogen replacement and coronary heart disease: a quantative assessment of the epidemiologic evidence. Prevent Med 1991;20:47-63.
3. Grady D, Rubin SM, Petitti DB, et al: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-1037.
4. Stevenson JC, Crook D, Godsland IF, et al: Hormone replacement therapy and the cardiovascular system. Nonlipid effects. Drugs 1994;47(suppl)2:35-41.
5. Pines A, Mijatovic V, van der Mooren MJ, et al: Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations. Eur J Obstet Gynaecol Reprod Biol 1997;71:193-197.
6. Mijatovic V, Pines A, Stehouwer CDA, et al: The effects of oestrogens on vessel wall and cardiac function, haemostasis and homocysteine metabolism. Eur J Menopause 1996;3:209-218.
7. Kon Koh K, Mincemoyer R, Bui MN, et al: Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med 1997;336:683-690.
8. Grodstein F, Stampfer MJ, Manson JE, et al: Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461.
9. Barrett-Connor E, Bush TL: Estrogen and coronary heart disease in women. JAMA 1991;265:1861-1867.
10. Bush TL, Barrett-Connor E, Cowan LD, et al: Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-1109.
11. Staessen J, Bulpitt CJ, Fagard R, et al: The influence of menopause on blood pressure. J Hum Hypertens 1989; 3:427-433.
12. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208.
13. Lip GYH, Beevers M, Churchill D, et al: Hormone replacement therapy and blood pressure in hypertensive women. J Hum Hypertens 1994;8:491-494.
14. Akkad AA, Halligan AW, Abrams K, et al: Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet Gynecol 1997;89:97-103.
15. Pripp UM, Hall G, Landgren BM, et al: The influence of long-term HRT treatment on ambulatory blood pressure in older women with coronary artery disease (Abst. F178). 8th International Congress on the Menopause, Sydney, Australia, November 3-7, 1996.
16. Casiglia E, D'Este D, Ginocchio G, et al: Lack of influence of menopause on blood pressure and cardiovascular risk profile: a 16 year longitudinal study concerning a cohort of 568 women. J Hypertens 1996;14:729-736.
17. Volterrani M, Rosano G, Coats A, et al: Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med 1995;99:119-122.
18. Riedel M, Oeltermann A, Mugge A, et al: Vascular responses to 17 beta-oestradiol in postmenopausal women. Eur J Clin Invest 1995;25:44-47.
19. Luotola H: Blood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitution. Ann Clin Res 1983;15(suppl 38):1-121.
20. Polderman KH, Stehouwer CDA, van der Kamp GJ, et al: Influence of sex hormones on plasma levels of endothelin. Ann Intern Med 1993;118:429-432.
21. Schwartz J, Freeman R, Frishman W: Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women. J Clin Pharmacol 1995;35:314-329.
22. Schunkert H, Danser AH, Hense HW, et al: Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997;95: 39-45.